Hepalink 8 million placing shares floating loss 134 million

This Friday, the Hepalink locked three months of the institutional placement unit faced with the lifting of the ban, while the June 5 listing of the other three SME stocks also face a total ban on placing shares.　　According to estimates, the 4 new shares, there are 3 of different degrees of institutional floating deficit, holding the more than 200 institutions of the sale of the shares of the Sea of Puri to the total billion on the floating deficit on the top. 8 million shares to bring hundreds of billions of floating losses 3 months ago, hepalink to 148 yuan high price, nearly two years listed high stock record to the extreme, May 6 on the day of the market, in the pursuit of funds, Hepalink more unexpectedly on the rush 188 Yuan peak. However, the performance of the magnificent show at the end of the moment, then the stock price collapse until the break.　　In such a context, 6th this month, the previous 200 institutions of the 8 million shares of the sale of the Puri shares will usher in a comprehensive lifting of the ban. According to Hepalink's public information, as early as the IPO period, the enthusiasm of the institution placement is very high, as many as 200 institutions have a total of 8 million shares, locking period of 3 months.　　Today, the release period from these institutions is only one trading day, but what about the current profit and loss of these funds? On the closing price of August 4, we calculated that the closing price of Hepalink 4th was $131.25, down 11.32% from the issue price, and the floating deficit of 8 million shares was $134 million. At the same time, the May 6-listed Construction research group locked the 6 million-unit placement unit, as well as the province-wide listing of the 4.12 million-share listed companies are also facing the problem of floating losses. The company closed its closing price of 25.01 Yuan on 4th, a 28 yuan down 10.68% from the offering price, so the shares of the unit floating deficit of 17.94 million yuan, the province wide share of the 4th close to 37.58 yuan, compared with the price of 39.8 Yuan fell 5.58%, which led to the stock placement agencies floating deficit of 9.15 million yuan.　　The only one of the institutions that has made a small profit is the development of technology, the shares of the 4th closing price of 37.59 Yuan rose 42.39% to 26.4 yuan, which makes the shares of 2.66 million shares float up to 29.76 million yuan. To cut out or to hold a stake in view of the lifting period these trapped institutional funds have to think about the way out of the placing stocks: if the future of the trend of the sea of Puri, then the institution can only admit to admit defeat, cut out of position, and if the stock continues to look forward to the future trend, it can not ignore the placement of the ban on the arrival　　Continue to feel at ease holding on to the rise. We will draw back to the performance of the sea, the first half of this year, the sea to the market to give a good answer: the first half of the parent company's net profit of 596 million yuan, an increase of 127.09%.　　In terms of detail, the first half of the normal grade heparin sodium raw materials to achieve income of 1.559 billion yuan, an increase of 285.71%; Despite a sharp drop in growth of more than 10 times times the 2009 annual report, a growth rate of 285% per cent in the background of such a high base is sufficient to demonstrate the exuberant demand for heparin sodium APIs. However, the value of the stock is not only determined by performance. Some analysts pointed out that hepalink higher price, has been to a certain extent overdrawn the company's future high growth, coupled with the medium-term market does not exist trend reversal, in this context, the influx of funds to hype the enthusiasm of high-priced stocks will not be too high. From this perspective, judging hepalink short-term return to the issue price, and significantly exceed the issue price is not a certainty.